2,2'-Dibenzothiazyl disulfide

DB14201ApprovedSmall moleculeStandardized Chemical Allergen

2,2'-Dibenzothiazyl disulfide is an accelerator used in the processing process for natural and synthetic rubber and plastic regeneration. It is also a known allergen and dermatological sensitizer. Sensitivity to 2,2'-Dibenzothiazyl... Sensitivity to 2,2'-Dibenzothiazyl disulfide may be identified with a clinical patch test.

Primary indication: 2,2'-Dibenzothiazyl disulfide is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.Curator reviewed
Formula / weight: C₁₄H₈N₂S₄ · 332.47 g/mol (avg)
First approval: United States, 2012
Also known as: Benzothiazole disulfide · Benzothiazolyl disulfide · BTS-SBT · DBTD · Dibenzothiazolyl disulfide

Resolves to

Compound

UNII6OK753033ZCAS120-78-5ChEMBLCHEMBL508112ChEBI53239

Clinical / RWD

RxNorm1306112

Structure

InChIKeyAFZSMODLJJCVPP-UHFFFAOYSA-NSMILESS(SC1=NC2=CC=CC=C2S1)C1=NC2=CC=CC=C2S1

Targets

P00390GSRQ16881TXNRD1

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Marketed productAcross 1 country and 1 labeller

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with 2,2'-Dibenzothiazyl disulfide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account